These data suggested that KIT mutations, especially those in exon 17, are related to a poor prognosis in AML with RUNX1-RUNX1T1, consistent with previous reports on the genetic profiling of R/R AML in patients with de novo AML [7,11,48,49,52]. Here, KIT is linked to acute myeloid leukemia.